Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
celgene
3
×
clinical trials
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
johnson & johnson
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
avexis
bayer
biogen
biotech
deals
eli lilly
fda
What
bio
news
3
×
roundup
drug
fda
nash
aducanumab
alzheimer’s
amyloid
angst
approved
august
bagged
billions
biogen
biogen’s
biotech
brammer
busy
companies
days
decisions
devices
digital
disease
drugs
effects
epidemic
failure
fatty
felt
frenzied
growing
known
led
legacy
liver
lost
merck
nods
Language
unset
Current search:
celgene
×
news
×
" bristol-myers squibb "
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More